Azienda ULSS 8 Berica

Vicenza 36100

0 studies enrolling now · 2 studies all time

What they study most

Advanced Cholangiocarcinoma, Advanced Colorectal Cancer, FGFR2 Gene Rearrangements

Studies at this site

• Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer — Completed
• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements — Stopped early